The MMTE/William Lieberman Saga Continues Mammoth

New Post Public Reply Private Reply Replies (1) Message Board
Kgem

The MMTE/William Lieberman Saga Continues

Mammoth Energy was a failed oil drilling company back when Overcash was the CEO.  At that time, MMTE had lawsuits filed by employees who Overcash refused to pay for their labor when the wells produced no oil.  MMTE was deep in debt, and could not drill on their leases because the employees made claims against all MMTE's oil lease properties.  Eventually, the board and management were given a vote of no confidence by shareholders, and this is when William Lieberman was brought in to plot a new direction --- this time lithium production.

Keep in mind, Lieberman was not an unknown.  William worked with Overcash on accounting and financial matters while Joe Overcash was CEO of MMTE.

Once the new board was elected, they voted Overcash out, and voted Lieberman in as the new CEO.  However, MMTE was completely broke at this point, and had liabilities as well as debts.  It was at this point that Overcash showed his close ties to William.  Joe Overcash offered to front William $40,000 to get MMTE up and running again, and launch it on its new direction questing for lithium concessions.  The M&A Advisors lawsuit proved that Overcash did pay William $40,000, but apparently transferred the note to his friends at STARR CONSULTING.  I detailed all the parties involved, as well as the names in prior posts on this board.

The $40,000 note accepted from Overcash had nothing to do with TTXP or BOPT or SIPP or anything else.  The money was for MMTE alone.  Overcash and his friends used MMTE as their own personal piggybank when he was CEO.  And, when he was voted out as CEO, he and his friends were very upset that this cash cow was taken away from them.  I suggest that Overcash offered William Lieberman the money, and William accepted, because it was Joe's plan to once again take control of MMTE, and continue his milking of the company.

Finally, to my knowledge, William paid nothing to take over MMTE (at least nothing publicly stated).  Lieberman was simply voted in as CEO because he already had knowledge of the operation and appeared more honest than Joe Overcash, even though the two worked together on financial and account matters.


When TTXP went dormant, William first eliminated the gold mining leases, and prior to gold, he eliminated the diamond concessions, and when MMTE changed from oil drilling to lithium, William eliminated the oil leases.  So what next?  The reverse split could come at any moment, and investors will be left with nothing at all, just like what happened with several of Lieberman's other adventures.

On 7/25/2012, William Lieberman, President of Mammoth, stated, "Our trading activity correlates with an equity capital raise with an institutional fund where the Company raised $220,000 USD for the purchase of MMTE's lithium assets a year ago.

Don't you find it strange that no one seems interested or is even asking where all the money went? I know individual investors purchased MMTE convertible debt for $25,000 - $50,000 - and even $100,000. We also know William employed several fund raising organizations or groups to raise capital for the purchase of lithium concessions, and William released news on several occasions stating that the capital raises were going quite well and were nearly complete --- this was stated for each and every capital raise. We also know "iron clad" who later turned out to be Brian MacDonald raised capital for MMTE, and did very well doing so. Finally, we certainly know that shares were issued (diluted big time) to raise money for concessions (can anyone forget that).

Now this is important for all MMTE investors to know and understand. William told me he did not need to pay for the concessions "up front" or all at once. Instead, he claimed in was paying for them in installments, and full payment was contingent on Chile approving lithium mining.

Remember, lithium concessions were basically worthless unless Chile changed its laws. So I ask once again, where did the money go? Why doesn't anyone see a need to know where the money went? Why isn't this topic discussed at all on IFlop?

Also important for MMTE investors to know and understand is that all William purchased was the right to explore and hopefully mine lithium at some point in time --- MMTE never actually purchase land.

As for mining, William made no preparation for such. Instead, he hoped someone or some other company would do that for him. The Atacama is a dry, barren, and lifeless desert. The land has little or no value, unless one can mine, and lithium mining is what gave it value. So without Chilean law changes regarding lithium mining, there is no value to the concessions. And, I stated many times, William likely lost the concessions and they have now reverted back to the original owners. MMTE investors are now left with nothing.




Strategic Asset Leasing Inc. (LEAS) Stock Research Links

LEAS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LiberNovo's Black Friday Chair Sale Tests Premium Demand

Updated Category News Views 81

Ergonomic chairs are not impulse purchases, and LiberNovo knows it. Its Black Friday push in the United States and Canada runs through November 30, throwing discounts, gifts, prize-wheel entries and loyalty points at buyers considering a fairly expensive piece of office equipment. That is a lot of promotional machinery for a chair sale, but the underlying pitch is...

Continue Reading
Pennsylvania Rebate Rules Matter Before Year-End Filing

Updated Category News Views 70

A missed rebate form can sting harder than most people expect, especially when a household has already spent the year watching property taxes, rent, groceries, and every other stubborn bill chew through fixed income. Pennsylvania’s Property Tax/Rent Rebate Program is not glamorous, and it is certainly not an investing story. It is, however, the kind of direct household...

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 199

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading
Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 82

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
MSD's AI Drug Bet Has Promise, but Plenty to Prove

Updated Category News Views 66

A promising molecule remains a very expensive guess until biology agrees. That is the sober lens for MSD's newly announced research collaboration with Isomorphic Labs: potentially meaningful science, certainly interesting strategic positioning, and absolutely no reason yet to start penciling in product sales. One Oncology Target, Not a Finished Drug On November 19, 2026,...

Continue Reading
LiberNovo's European Black Friday Sale Tests Demand

Updated Category News Views 139

A €1,339 chair has no business pretending it is an impulse buy, which is exactly why LiberNovo’s Black Friday push deserves a closer look. The Hong Kong-based ergonomic-chair seller has rolled out its Black Friday sale across the European Union and United Kingdom, with the campaign ending November 30 at 23:59 CET in the EU and 23:59 GMT in the UK. This is a...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 150

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
Aimbient's OR Timestamp Study Puts Efficiency to Test

Updated Category News Views 160

A camera catching a patient’s arrival on time may sound mundane, but operating rooms are where mundane details can turn into serious money and better operational decisions. Aimbient’s newly corrected announcement points to an independently conducted Stanford Medicine study in JAMA Surgery that tested whether its computer-vision system could document key operating-room...

Continue Reading
Thanksgiving AI Talk Needs Better Safety Questions

Updated Category News Views 108

Thanksgiving has somehow acquired a new household hazard: somebody casually pasting private information into a chatbot between football and dessert. SBS CyberSecurity’s point is sensible, and it lands because this is no longer a niche tech habit. Pew Research Center says 49% of U.S. adults use AI chatbots, up from roughly one-third in 2024. That kind of adoption curve...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 87

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading

Top 5 Most Recently Viewed Articles

Japan's Economic Outlook Dims as Export Weakness Persists

Updated Category News Views 189

Japan's Revised Economic Growth Forecast Recently, Japan's government announced a downward revision of its GDP growth forecast for the current fiscal year. This adjustment is significant as it reflects the ongoing struggles within the economy, particularly in light of weaker export performance that is hindering a fragile recovery. Details on the Growth Projection The...

Continue Reading
The Importance of Employee Recognition in the Workplace

Updated Category News Views 254

The Importance of Employee Recognition in the Workplace Gratitude is a key theme during Thanksgiving, but in the workplace, recognition for employee contributions plays an equally significant role throughout the year. As companies strive to enhance their workplace culture, the value of recognizing employees cannot be overstated. Understanding Employer Perspectives A...

Continue Reading
Class Action Alert for Shareholders of Orthofix Medical

Updated Category News Views 196

Class Action Lawsuit Overview In the current landscape of securities litigation, investors in Orthofix Medical, Inc. have a critical opportunity to engage with a class action lawsuit that addresses significant issues of corporate governance and transparency. This legal action has arisen following severe corporate management changes that have caused share price...

Continue Reading
Understanding Recent Trends in Lowe's Short Interest

Updated Category News Views 107

Understanding Lowe's Companies' Short Interest Lowe's Companies (NYSE: LOW) has seen its short percent of float decrease by 12.78% since the last report. Currently, there are approximately 6.55 million shares sold short, which constitutes 1.16% of all shares available for trading. Given the current trading volume, it would take traders about 2.91 days to cover their short...

Continue Reading
YD Bio Limited and EG Biomed Enhance Clinical Testing with CAP Accreditation

Updated Category News Views 151

Transformative Advancements in Clinical Testing by YD Bio Limited YD Bio Limited, a pioneering biotechnology company known for its advancements in DNA methylation-based cancer detection, recently celebrated a significant milestone through its collaboration with EG Biomed US Inc. This partnership has propelled forward the capabilities of clinical testing, particularly in...

Continue Reading